Gray Nancy Ryan
- SEC CIK
- 0001714949
In the past year, 1 open-market sale filing worth $1.35M and no purchases.
Current role at each company
- LGND Ligand Pharmaceuticals IncDirectoras of Jun 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.35M
- 1 filing
- Net
- −$1.35M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Gray Nancy Ryan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 (view filing) | Nov 7 | 5 days | Gray Nancy RyanDirector | SSale | −6.57K | $205.45 | −$1.35M | −44.8%8.09K after | 2 lots |
| May 17, 2024 (view filing) | May 9 | 8 daysLate | Gray Nancy RyanDirector | SSale | −934 | $83.20 | −$77.7K | −14.2%5.63K after |